A once-daily pill halved people’s risk of dying from a common lung cancer when they took the drug after tumour-removal surgery, trial results from a global study shows
A once-daily pill halved people’s risk of dying from a common lung cancer when they took the drug after tumour-removal surgery, trial results from a global study shows
Disclaimer: Stories/articles published under EM Buzz (eastmojo.com/em-buzz) are provided by third parties and EastMojo.com has no direct relation with these articles.
Sign in to activate your ad-free experience.
Enter your membership email and we'll send you a secure login link.
Not a member yet? Become a Member →